Sep 11
At the University of North Carolina (UNC) School of Medicine, researchers in its Laboratory for Retinal Rehabilitation have been studying the potential of a class of drugs aimed at inhibiting MDM2
proteins that occur in the eyes of patients with age-related macular
degeneration (AMD). Positve results in testing these inhibitors in mice
models of the disease suggest a promising path to treatment of AMD, a
disease that affects 11 million persons in the U.S. alone.
Post a Comment